CXCR4 and lung carcinoma: The elevation of circFGFR1 reduces PD-1-positive lung cancer cell and CD8+ T cell frequency by regulating the miR-381-3p/C-X-C motif chemokine receptor 4 (CXCR4) axis, which is responsible for reduced sensitivity to anti-PD-1 antibodies [120].